{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-077546","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2026-06-25T12:01:26+00:00","discovered_at":"2026-06-25T12:05:00.304963+00:00","generated_at":"2026-06-25T12:05:25.718646+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"NextCure shareholders elect directors, approve amended equity plan with 80,000 additional shares","bullets":["Anne Borgman, M.D. and John G. Houston, Ph.D. reelected as Class I directors for 3-year terms.","Shareholders approved amendment and restatement of 2019 Omnibus Incentive Plan, increasing authorized shares by 80,000.","Ratification of Ernst & Young LLP as independent auditor for fiscal 2026 passed with 2,774,832 votes for.","Advisory vote on executive compensation passed with 2,109,269 votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-077546","json":"https://secwatch.observer/filing/0001104659-26-077546.json","markdown":"https://secwatch.observer/filing/0001104659-26-077546.md","text":"https://secwatch.observer/filing/0001104659-26-077546.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000110465926077546/0001104659-26-077546-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000110465926077546/nxtc-20260618x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T12:05:25.718646+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}